Pavol Kováč Selected Research

O Antigens (O Antigen)

11/2021	Scalable production and immunogenicity of a cholera conjugate vaccine.
7/2021	Correction: Plasma and memory B cell responses targeting O-specific polysaccharide (OSP) are associated with protection against Vibrio cholerae O1 infection among household contacts of cholera patients in Bangladesh.
1/2021	Parenteral Vaccination with a Cholera Conjugate Vaccine Boosts Vibriocidal and Anti-OSP Responses in Mice Previously Immunized with an Oral Cholera Vaccine.
1/2021	Defining Polysaccharide-Specific Antibody Targets against Vibrio cholerae O139 in Humans following O139 Cholera and following Vaccination with a Commercial Bivalent Oral Cholera Vaccine, and Evaluation of Conjugate Vaccines Targeting O139.
11/2020	Humans Surviving Cholera Develop Antibodies against Vibrio cholerae O-Specific Polysaccharide That Inhibit Pathogen Motility.
11/2019	Immune responses to O-specific polysaccharide (OSP) in North American adults infected with Vibrio cholerae O1 Inaba.
1/2019	Bivalent oral cholera vaccination induces a memory B cell response to the V. cholerae O1-polysaccharide antigen in Haitian adults.
1/2019	Induction of systemic, mucosal and memory antibody responses targeting Vibrio cholerae O1 O-specific polysaccharide (OSP) in adults following oral vaccination with an oral killed whole cell cholera vaccine in Bangladesh.
1/2018	Plasma and memory B cell responses targeting O-specific polysaccharide (OSP) are associated with protection against Vibrio cholerae O1 infection among household contacts of cholera patients in Bangladesh.
1/2018	Anti-O-specific polysaccharide (OSP) immune responses following vaccination with oral cholera vaccine CVD 103-HgR correlate with protection against cholera after infection with wild-type Vibrio cholerae O1 El Tor Inaba in North American volunteers.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pavol Kováč Research Topics

Disease

19	Cholera 11/2021 - 10/2011
7	Infections 07/2021 - 12/2016
1	Diarrhea 01/2018
1	Convalescence 01/2016
1	Bacterial Infections (Bacterial Infection) 10/2011

Drug/Important Bio-Agent (IBA)

14	O Antigens (O Antigen)IBA 11/2021 - 10/2013
8	AntigensIBA 11/2021 - 10/2011
8	Cholera Vaccines FDA Link 11/2021 - 05/2014
6	Conjugate VaccinesIBA 11/2021 - 10/2011
6	Immunoglobulin A (IgA)IBA 01/2021 - 05/2014
6	Immunoglobulin M (IgM)IBA 01/2021 - 05/2014
6	VaccinesIBA 01/2021 - 10/2011
5	Polysaccharides (Glycans)IBA 01/2021 - 02/2014
5	AntibodiesIBA 01/2021 - 12/2016
3	Immunoglobulin G (IgG)IBA 01/2021 - 05/2014
3	LipopolysaccharidesIBA 01/2018 - 05/2014
2	Phosphates (Orthophosphate)IBA 01/2021 - 01/2021
2	cholera vaccine CVD 103-HgRIBA 01/2021 - 01/2018
2	Tetanus Toxoid (Vaccine, Tetanus)FDA Link 01/2021 - 02/2014
2	Monoclonal AntibodiesIBA 11/2020 - 12/2016
2	Cholera ToxinIBA 11/2019 - 01/2016
2	Tetanus ToxinIBA 01/2015 - 10/2013
1	Bacterial PolysaccharidesIBA 11/2021
1	CarbohydratesIBA 01/2021
1	Capsules (Microcapsules)IBA 01/2021
1	colitoseIBA 01/2021
1	BuffersIBA 01/2021
1	Blood Group Antigens (Blood Groups)IBA 11/2019
1	OligosaccharidesIBA 01/2019
1	Neuraminidase (Sialidase)IBA 12/2016
1	shancholIBA 01/2016
1	squaric acidIBA 01/2015
1	Proteins (Proteins, Gene)FDA Link 10/2011